FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy
Nóra Garam(Semmelweis University), Romana Ryšavá(Charles University), Tanja Kersnik Levart(Ljubljana University Medical Centre), Rina Rus(Ljubljana University Medical Centre), Ernesta Mačionienė(Vilnius University), Kata Kelen(Semmelweis University), Mária Sinkó(University of Szeged), Csaba Bereczki(University of Szeged), Anamarija Meglič(Ljubljana University Medical Centre), Attila Iliás(Eötvös Loránd University), Marcell Cserhalmi(Eötvös Loránd University), Nóra Klenk(University of Miskolc), Klaus Arbeiter(Medical University of Vienna), Johannes Hofer(Johannes Kepler University of Linz), Adrian Lungu(Institutul Clinic Fundeni), Zoltán Prohászka(Semmelweis University), Barbara Uzonyi(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Dóra Bajcsi(University of Szeged), Gere Sunder–Plassmann(University of Vienna), Andreas Heilos(Medical University of Vienna), Krisztina Kóbor(University of Miskolc), Agnès Haris(Péterfy Sándor Utcai Kórház-Rendelőintézet és Baleseti Központ), Dániel Jakab(University of Szeged), Stefan Flaschberger(Klinikum Klagenfurt), Tomasz Stompór(University of Warmia and Mazury in Olsztyn), Gert Mayer(University of Vienna), Marius Miglinas, Daniel Cejka(Krankenhaus der Elisabethinen), Michael Rudnicki(Innsbruck Medical University), Alice Schmidt, Ágnes Szilágyi(Semmelweis University), Viktor Jankó(Medirex Group Academy), Maarten Knechtelsdorfer(Wilhelminen Hospital), Edina K. Szabo(Semmelweis University), Martina Gaggl(Medical University of Vienna), Ágnes Hartmann(University of Pecs), Christof Aigner(Medical University of Vienna), Nika Kojc(University of Ljubljana), Ľudmila Podracká(Boston Children's Hospital), Hana Flögelová(University Hospital Olomouc), Nóra Veszeli(Semmelweis University), Anna Pawłowska(City of Hope), Erika Szigeti(University of Szeged), Attila J. Szabó(Semmelweis University), Mario Laganović(University of Zagreb), Alexandra Dumfarth(Krankenhaus der Elisabethinen), Thomas Mueller(Medical University of Vienna), Krisztina Rusai(Comprehensive Cancer Center Vienna), Jürgen Brunner(Innsbruck Medical University), György Reusz(Semmelweis University)
Cited by 20
Related Papers
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|609
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345
Defects in the IFT-B Component IFT172 Cause Jeune and Mainzer-Saldino Syndromes in Humans
|The American Journal of Human Genetics|2013|232